在SURMOUNT-2中，替西肽对超重或肥胖和2型糖尿病成人的减重效果因基线HbA1c类别而有显著差异。

{"title":"在SURMOUNT-2中，替西肽对超重或肥胖和2型糖尿病成人的减重效果因基线HbA1c类别而有显著差异。","authors":"Naveed Sattar, Gema Frühbeck, Fabrizio Andreelli, Luis-Emilio García-Pérez, Dachuang Cao, Adam Stefanski, Fatih Tangi, Gary Grant, Imane Benabbad","doi":"10.2337/dc25-1442","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":93979,"journal":{"name":"Diabetes care","volume":" ","pages":""},"PeriodicalIF":16.6000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Weight Reduction With Tirzepatide Varied Meaningfully by Baseline HbA1c Category in Adults With Overweight or Obesity and Type 2 Diabetes in SURMOUNT-2.\",\"authors\":\"Naveed Sattar, Gema Frühbeck, Fabrizio Andreelli, Luis-Emilio García-Pérez, Dachuang Cao, Adam Stefanski, Fatih Tangi, Gary Grant, Imane Benabbad\",\"doi\":\"10.2337/dc25-1442\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":93979,\"journal\":{\"name\":\"Diabetes care\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":16.6000,\"publicationDate\":\"2025-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2337/dc25-1442\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/dc25-1442","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}